selecting and managing patients for targeted therapies and immunotherapies for lung cancer
Published 7 years ago • 77 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
2:18
choosing the best immunotherapy regimen for lung cancer
-
6:08
targeted therapy and immunotherapy for lung cancer | dr. laura chow
-
2:28
how to monitor and manage immunotherapy related events in lung cancer
-
9:37
precision medicine: targeted treatment for lung cancer
-
2:41
new targeted and immunotherapy options in lung cancer
-
4:03
landscape of targeted therapies in lung cancer
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
0:58
dr. keith kerr on selecting patients for immunotherapy in lung cancer
-
5:35
an innovative approach to cancer treatment – targeted therapy and immunotherapy
-
4:08
targeted therapies in lung cancer
-
1:00:09
new options for lung cancer therapies
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
1:51
small cell lung cancer may respond to combination of immunotherapy and targeted therapy
-
2:43
clinical factors in the selection of patients for first-line immunotherapy of lung cancer
-
1:20
the crossroads of targeted therapy and immunotherapy in lung cancer
-
2:24
advancing lung cancer therapy: from palliative chemotherapy to immunotherapy
-
4:15
the toxicities associated with immunotherapy in lung cancer patients
-
2:40
targeted therapies for lung cancer: challenges in side effect management.